Oncorus, Inc. - 68236R103
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2023
· Q4 2022
Value (USD)
Total reported value ($000)
$558K
QoQ value delta ($000)
-$1.054M
(-65.38%)
Implied price effect (QoQ)
+34.79%
Shares
Total shares
1,641,306
QoQ shares delta
-4,749,887
(-74.32%)
Total shares held by funds (by quarter)
Top holders (Q1 2023)
Top 25 only
Full list
Early Q2 2023 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 163 | 475,345 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 99 | 286,667 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 50 | 144,000 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 46 | 135,751 | 0.0% |
| MGO ONE SEVEN LLC | 40 | 116,354 | 0.0% |
| TWO SIGMA ADVISERS, LP | 26 | 75,712 | 0.0% |
| STATE STREET CORP | 24 | 70,135 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23 | 67,300 | 0.0% |
| Bank of New York Mellon Corp | 22 | 66,498 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 17 | 51,680 | 0.0% |
| CITADEL ADVISORS LLC | 10 | 30,299 | 0.0% |
| NORTHERN TRUST CORP | 9 | 28,525 | 0.0% |
| HSBC HOLDINGS PLC | 8 | 26,452 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 6 | 17,525 | 0.0% |
| UBS Group AG | 5 | 14,650 | 0.0% |
| BARCLAYS PLC | 3 | 9,495 | 0.0% |
| GOLDMAN SACHS GROUP INC | 3 | 10,195 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 8,581 | 0.0% |
| MORGAN STANLEY | 1 | 4,506 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 353 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 823 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 135 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 225 | 0.0% |
| Allworth Financial LP | 0 | 100 | 0.0% |